Andrzej Mogielnicki
Andrzej Mogielnicki
Medical University of Bialystok
Zweryfikowany adres z umb.edu.pl - Strona główna
TytułCytowane przezRok
1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway
S Chlopicki, J Swies, A Mogielnicki, W Buczko, M Bartus, M Lomnicka, ...
British journal of pharmacology 152 (2), 230-239, 2007
1462007
THE PHYSIOLOGICAL SIGNIFICANCE OF THE ALTERNATIVE
K Kramkowski, A Mogielnicki, W Buczko
Journal of physiology and pharmacology 57 (4), 529-539, 2006
982006
L-arginine and cardiovascular system
D Cylwik, A Mogielnicki, W Buczko
Pharmacol Rep 57 (1), 14-22, 2005
682005
Angiotensin II enhances thrombosis development in renovascular hypertensive rats
A Mogielnicki, E Chabielska, R Pawlak, J Szemraj, W Buczko
Thrombosis and haemostasis 93 (06), 1069-1076, 2005
622005
IN FOCUS: A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity–a staphylokinase variant. I. In vitro study
J Szemraj, B Walkowiak, I Kawecka, G Janiszewska, W Buczko, ...
Journal of Thrombosis and Haemostasis 3 (10), 2156-2165, 2005
522005
ANGIOTENSIN II VIA AT1 RECEPTOR ACCELERATES ARTERIAL
M Kaminska, A Mogielnicki, A Stankiewicz, K Kramkowski, ...
Journal of physiology and pharmacology 56 (4), 571-585, 2005
462005
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules
K Kramkowski, A Leszczynska, A Mogielnicki, S Chlopicki, A Fedorowicz, ...
Arteriosclerosis, thrombosis, and vascular biology 32 (9), 2149-2157, 2012
452012
Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors
S Chlopicki, M Lomnicka, A Fedorowicz, E Grochal, K Kramkowski, ...
Naunyn-Schmiedeberg's archives of pharmacology 385 (6), 641-650, 2012
432012
The toxicology of heparin reversal with protamine: past, present and future
E Sokolowska, B Kalaska, J Miklosz, A Mogielnicki
Expert opinion on drug metabolism & toxicology 12 (8), 897-909, 2016
412016
ANTITHROMBOTIC EFFECT OF TISSUE AND PLASMA TYPE
M Wojewódzka-Elezniakowicz, E Chabielska, A Mogielnicki, ...
Journal of physiology and pharmacology 57 (2), 231-245, 2006
352006
Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis
B Kalaska, E Sokolowska, K Kaminski, K Szczubialka, K Kramkowski, ...
European journal of pharmacology 686 (1-3), 81-89, 2012
332012
N-methylnicotinamide inhibits arterial
A Mogielnicki, K Kramkowski, L Pietrzak, W Buczko
Journal of Physiology and Pharmacology 58 (3), 515-527, 2007
302007
Aspirin and the fibrinolytic response
W Buczko, A Mogielnicki, K Kramkowski, E Chabielska
Thrombosis research 110 (5-6), 331-334, 2003
292003
Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats
K Kramkowski, A Mogielnicki, A Leszczynska, W Buczko
Journal of Physiology and Pharmacology 61 (3), 317, 2010
272010
Antithrombotic effects of pyridinium compounds formed from trigonelline upon coffee roasting
B Kalaska, L Piotrowski, A Leszczynska, B Michalowski, K Kramkowski, ...
Journal of agricultural and food chemistry 62 (13), 2853-2860, 2014
242014
Antithrombotic effect of L-arginine in hypertensive rats
D Cylwik, A Mogielnicki, K Kramkowski, J Stokowski, W Buczko
Journal of physiology and pharmacology 55 (3), 563-574, 2004
242004
Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin
B Kalaska, K Kaminski, E Sokolowska, D Czaplicki, M Kujdowicz, ...
PloS one 10 (3), 2015
222015
A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity–a staphylokinase variant
J Szemraj, A Stankiewicz, W Rozmyslowicz-Szermńska, A Mogielnicki, ...
Thrombosis and haemostasis 98 (06), 1037-1045, 2007
192007
Are the endothelial mechanisms of ACE-Is already established?
W Buczko, K Kramkowski, A Mogielnicki
Pharmacological Reports 58, 126, 2006
182006
Nicotinamide and its metabolite N‐methylnicotinamide increase skin vascular permeability in rats
L Pietrzak, A Mogielnicki, W Buczko
Clinical and Experimental Dermatology: Experimental dermatology 34 (3), 380-384, 2009
162009
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20